Pharmafile Logo
Pharmafocus logo
Advanced Search

Unions vote against NHS ‘privatisation’

October 13, 2005

The government lost the vote at its party conference on expanding the role of the private sector in the NHS.A …

News

VNU shareholders rebel over IMS bid

October 13, 2005
Sales and Marketing

A significant minority of shareholders in VNU are against its planned $7 billion acquisition of pharmaceutical information company IMS Health.The …

News

Reducing POM to P headaches

October 12, 2005
Sales and Marketing

Following an eight-week period of public consultation, the Committee on Safety of Medicines is to shortly advise health ministers about …

Feature

Creative Lynx to work on Novartis transplantation brands

October 12, 2005
Medical Communications

Novartis has awarded advertising accounts for its ophthalmology and transplantation portfolios to Manchester-based advertising agency Creative Lynx.The pharma company held …

News

GPs need pharma expertise

October 5, 2005

GPs are calling out for pharmaceutical companies to provide them with management skills as they take on a new role …

News

Resolute selected for IBD campaign

October 3, 2005
Medical Communications

Procter & Gamble has chosen Resolute Communications to conduct a combined PR and medical education programme for its inflammatory bowel …

News

Pharma cast as ‘bad guys’ in Hollywood blockbuster

September 30, 2005
Sales and Marketing

A new Hollywood thriller featuring the pharmaceutical industry as the 'bad guys' is to hit UK screens next week.The Constant …

News

Genzyme opens first European research centre in Cambridge

September 30, 2005
Research and Development

Genzyme, one of the most successful US biotech companies, has opened its first European research centre in Cambridge, UK – …

News

Davis to leave Takeda UK

September 30, 2005
Sales and Marketing

Andy Davis, the high-profile managing director of Takeda UK is to leave the company.Davis is best known for overseeing a …

News

New leader for FDA in turmoil

September 30, 2005
Sales and Marketing

Andrew von Eschenbach has been appointed the new acting head of the FDA after the surprise resignation of Lester Crawford.Crawford …

News

NICE seeks urgent fix for slow appraisals

September 29, 2005
Sales and Marketing

Patients waiting for access to new, more effective medicines could be prescribed them earlier if new proposals are adopted.NICE, the …

News

The inspector calls

September 28, 2005
Research and Development

I have become a pharmacovigilance bore within my company, a prophet of doom. It is worse than that, because for …

Feature

Astellas launches Flomaxtra XL

September 27, 2005
Sales and Marketing

Astellas has launched Flomaxtra XL, a new treatment for the symptoms of BPH or benign prostatic hyperplasia.The condition is the …

News
Sains

Lilly increasing investment in UK R&D

September 23, 2005
Research and Development

 Lilly has opened a new  £26 million UK research facility, a move which underlines its commitment to developing medicines in …

News

Novartis pipeline promises cardiovascular advances

September 22, 2005
Research and Development

Novartis hopes to expand its presence in cardiovascular medicine with the filing next year of two potentially first-in-class products with …

News

US rejects Pfizer’s injectable Cox-II

September 22, 2005
Sales and Marketing

The FDA has denied approval for Pfizer's injectable pain drug Dynastat, delivering a fresh blow to the embattled Cox-II class …

News

NICE to review guidance on hypertension treatments

September 22, 2005
Research and Development

NICE has set up a specialist advisory group to review new data which could lead to thousands of heart patients …

News

Roche’s Tarceva approved in Europe

September 21, 2005
Sales and Marketing

News

Once a month osteoporosis pill launched

September 21, 2005
Sales and Marketing

News

New data gives Seretide upper hand in respiratory battle

September 20, 2005
Sales and Marketing

Seretide's domination in the global respiratory market looks set to be bolstered by a new head to head study with …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026